oral glp 1 medication FDA Grants Speedy Approval to Eli Lilly's GLP-1 RA Drug for Obesity New research suggests GLP-1 medication,
Description
FAQs Who is not a good candidate for GLP-1
Skeptical or anti-GLP-1 viewpoints made up a relatively small share of overall discussions on X, but they generated outsized engagement
WHY IT MATTERS Because you don't want to be smaller and weaker
The company is advancing next-generation oral and injectable treatments and raised $411M in an oversubscribed Series A round, co-led by Forbion and General Atlantic, with participation from RA Capital Management, OrbiMed, Logos Capital, Lilly Asia Ventures, and LYFE Capital
Should You Stop Taking GLP-1 Drugs
